VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

PROSCA BLADDR 2021 | New agents and novel trials in advanced UC

Petros Grivas, MD, PhD, Seattle Cancer Care Alliance, Seattle, WA, discusses new agents and novel trials in advanced urothelial carcinoma (UC), including the use of antibody-drug conjugates, FGFR inhibitors and the promise of combination therapies and biomarkers. This interview took place at the PROSCA/BLADDR 2021 congress.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter